Ann: Fluence June 2019 Quarterly Report Business Update, page-17

22 Aug 2016Emefcy Group announced the signing of three key agreements, which collectively will help to enable the Company's plans to establish a Company owned and operated state of the art high-volume manufacturing facility in the Chinese province of Jiangsu. The first production line (Phase 1) is due to be completed and installed by mid-2017 and is anticipated to support up to A$100m in product sales annually. When fully implemented, this facility is anticipated to support up to A$400m in annual turnover and provide the majority of the Company's global manufacturing needs for its MABR based wastewater treatment solutions. The Company anticipates the capital cost of the production line (Phase 1) to be A$1.5m inclusive of logistics and installation costs.